(Reuters) -European shares opened lower on Monday, after rounding off monthly gains in May, as U.S. President Donald Trump's ...

Futures on Wall Street have begun trading on Sunday evening US time on a negative note amidst rising uncertainties on trade ...

President Trump said Friday that tariffs on imported steel and aluminum would increase to 50% from 25%, effective Wednesday. Australian investment manager Washington H. Soul Pattinson and ...

PARIS (Reuters) -French pharma group Sanofi has agreed to buy US-based Blueprint Medicines Corporation, a biopharmaceutical ...

Sanofi SA will buy Blueprint Medicines Corp. for $9.1 billion equity value, in a deal that sees the European pharmaceutical ...

The deal includes a drug approved in the U.S. and the EU for systemic mastocytosis, a rare immunology disease, as well as an ...

French pharma group Sanofi has agreed to buy US-based Blueprint Medicines Corporation , a biopharmaceutical company ...

Arguably the most notable of the FDA’s upcoming decisions is that regarding Gilead’s twice-yearly HIV prophylaxis lenacapavir ...

Paris: Sanofi has announced that the AERIFY-1 phase 3 study evaluating itepekimab in former smokers with inadequately ...

This symposium, ‘A case-based approach to navigating treatment switch in late-onset Pompe Disease (LOPD)’, was held at the ...